Cramer Rosenthal McGlynn’s BioLife Solutions BLFS Stock Holding History

Cramer Rosenthal McGlynn’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.3M	Sell	575,792 -57,020	-9%	-$1.33M	0.82%	44
2026 Q1	$12.1M	Buy	+632,812	New	+$14M	0.89%	41
2025 Q4	–	Sell	-96,590	Closed	-$2.46M	–	89
2025 Q3	$2.46M	Sell	96,590 -607,565	-86%	-$14.4M	0.15%	90
2025 Q2	$15.2M	Buy	704,155 +19,770	+3%	+$446K	1.04%	39
2025 Q1	$15.6M	Sell	684,385 -221,367	-24%	-$5.83M	1.13%	39
2024 Q4	$23.5M	Sell	905,752 -196,907	-18%	-$4.9M	1.33%	30
2024 Q3	$27.6M	Sell	1,102,659 -198,170	-15%	-$4.68M	1.53%	27
2024 Q2	$27.9M	Buy	1,300,829 +133,601	+11%	+$2.59M	1.64%	19
2024 Q1	$21.7M	Buy	+1,167,228	New	+$20.4M	1.18%	38

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cramer Rosenthal McGlynn's BLFS Position: Q2 2026 in Review

Cramer Rosenthal McGlynn reduced its BioLife Solutions (BLFS) stake by 9% in Q2 2026, selling an estimated $1.33M and leaving 575,792 shares worth $16.3M. The position accounts for 0.82% of the portfolio, ranked #44.

Cramer Rosenthal McGlynn first reported a position in BLFS in Q1 2024 and has held it in 9 quarters since. The position peaked at $27.9M in Q2 2024. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

Cramer Rosenthal McGlynn held 575,792 shares of BioLife Solutions worth $16.3M as of Q2 2026.
Cramer Rosenthal McGlynn sold 57,020 BioLife Solutions shares in Q2 2026, an estimated $1.33M.
BioLife Solutions made up 0.82% of Cramer Rosenthal McGlynn's portfolio in Q2 2026, its #44 holding.
Cramer Rosenthal McGlynn first reported a position in BioLife Solutions in Q1 2024 and has held it in 9 quarters since.
Cramer Rosenthal McGlynn's BioLife Solutions position peaked at $27.9M in Q2 2024.
216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Cramer Rosenthal McGlynn's 13F filing for Q2 2026, filed 13 Aug 2026.